Abstract:Abstract Background The pathogenesis of Alzheimer’s disease (AD) varies greatly depending on environmental and heritable factors. Neuropathological scores aid in the understanding of disease severity in postmortem tissue, but fail to provide insights into disease onset and progression. Conversely, mouse models of AD like 5XFAD offer predictable timelines of amyloid accumulation due to specific human AD risk signals, but have limitations due to species differences. Studying AD in Down Syndrome (AD in DS) patients provides an opportunity to study the transcriptomics of AD progression due to overexpression of APP , which results in a more predictable disease time course compared to the more stochastic disease progression in the general population. Method We present a rigorous transcriptomic analysis of AD using single‐nucleus RNA‐seq (snRNA‐seq) and spatial transcriptomics (ST) in cortical samples from donors with early‐stage AD, late‐stage AD, AD in DS, and cognitively normal controls. We performed ST (10X Genomics Visium) in these groups, and additionally performed snRNA‐seq (Parse Biosciences) in tissue from AD in DS donors and controls. Finally, we profiled 5XFAD and wild type mice at four time points (4, 6, 8, and 12 months) using ST to facilitate cross‐species comparisons. We applied state‐of‐the‐art bioinformatic and statistical approaches to integrate these datasets with published AD snRNA‐seq data and to perform systematic analyses of gene expression and gene networks in these groups. Result We found shared and distinct differentially expressed genes (DEGs) between AD and AD in DS in the ST and snRNA‐seq datasets, with greater concordance in neuronal cell types compared to glia. Cell‐cell communication network analysis of integrated snRNA‐seq and ST data revealed vast network remodeling in disease, highlighting an increase in WNT and ANGPTL signaling and a decrease in CD99 signaling among other disrupted pathways. Using geospatial statistical analysis, we identified amyloid plaque proximal DEGs in human and mouse ST data, which were largely species‐specific with little overlap. Conclusion The primary data generated here will be a valuable resource for the AD community, and our study provides new insights into the transcriptomics of AD and amyloid pathology by performing a holistic analysis considering sporadic and genetic forms of AD.

Untangling Alzheimer's disease with spatial multi-omics: a brief review

Spatial Multi-Omics in Alzheimer's Disease: A Multi-Dimensional Approach to Understanding Pathology and Progression

Unraveling Alzheimer's disease: insights from single-cell sequencing and spatial transcriptomic

Mapping the Alzheimer's brain with connectomics.

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease

Integrated spatial and single‐cell transcriptomic analysis of genetic and sporadic forms of Alzheimer’s disease

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease

Multi-omics Analysis Reveals the Key Factors Involved in the Severity of the Alzheimer’s Disease

Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease

Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer's Disease

An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease

Gene networks and systems biology in Alzheimer's disease: Insights from multi‐omics approaches

Integration of Single-Cell and Spatial Transcriptomic Data Reveals Spatial Architecture and Potential Biomarkers in Alzheimer's Disease

Spatial Multiomics Analysis in Psychiatric Disorders.

Integrated multimodal cell atlas of Alzheimer’s disease

New molecular approaches to Alzheimer's disease

Integrated multi-omics analysis of Alzheimer's disease shows molecular signatures associated with disease progression and potential therapeutic targets

Integrated multimodal cell atlas of Alzheimer's disease

Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease

Alzheimer's Disease: Exploring the Landscape of Cognitive Decline